Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.

Gibson CR, Staubus AE, Barth RF, Yang W, Ferketich AK, Moeschberger MM.

J Neurooncol. 2003 Mar-Apr;62(1-2):157-69.

PMID:
12749711
2.

Electrospray ionization mass spectrometry coupled to reversed-phase ion-pair high-performance liquid chromatography for quantitation of sodium borocaptate and application to pharmacokinetic analysis.

Gibson CR, Staubus AE, Barth RF, Yang W, Kleinholz NM, Jones RB, Green-Church KB, Tjarks W, Soloway AH.

Anal Chem. 2002 May 15;74(10):2394-9.

PMID:
12038766
3.

Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.

Gibson CR, Staubus AE, Barth RF, Yang W, Kleinholz NM, Jones RB, Green-Church K, Tjarks W, Soloway AH.

Drug Metab Dispos. 2001 Dec;29(12):1588-98.

PMID:
11717178
4.

High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose.

Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR.

Ann Pharmacother. 2000 Oct;34(10):1146-51.

PMID:
11054983
5.

Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.

Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.

Neurosurgery. 2000 Sep;47(3):608-21; discussion 621-2.

PMID:
10981748
6.

Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.

Hamlar DD, Schuller DE, Gahbauer RA, Buerki RA, Staubus AE, Hall J, Altman JS, Elzinga DJ, Martin MR.

Laryngoscope. 1996 Aug;106(8):972-6.

PMID:
8699911
7.

Peritoneal carcinomatosis and radioimmunoguided surgery.

Schneebaum S, Arnold MW, Staubus AE, Martin EW Jr.

Cancer Treat Res. 1996;82:193-209.

PMID:
8849951
8.

A nude rat model for neutron capture therapy of human intracerebral melanoma.

Barth RF, Matalka KZ, Bailey MQ, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1079-88.

PMID:
8175392
9.

Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.

Matalka KZ, Barth RF, Staubus AE, Moeschberger ML, Coderre JA.

Radiat Res. 1994 Jan;137(1):44-51.

PMID:
8265787
10.

Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.

Matalka KZ, Bailey MQ, Barth RF, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK.

Cancer Res. 1993 Jul 15;53(14):3308-13.

11.
12.

Boron neutron capture therapy of a rat glioma.

Clendenon NR, Barth RF, Gordon WA, Goodman JH, Alam F, Staubus AE, Boesel CP, Yates AJ, Moeschberger ML, Fairchild RG, et al.

Neurosurgery. 1990 Jan;26(1):47-55.

PMID:
2294479
13.

DISIDA kinetics measure liver function in dogs.

Fraser IA, Shaffer P, Staubus AE, Tuttle S, Carey LC, Ellison EC.

Nucl Med Commun. 1989 Jun;10(6):435-47.

PMID:
2771304
14.

Enhanced survival in a rat glioma model following BNCT.

Clendenon NR, Barth RF, Goodman JH, Staubus AE, Gordon WA, Moeschberger ML, Alam F, Soloway AH, Fairchild RG, Slatkin DN, et al.

Strahlenther Onkol. 1989 Feb-Mar;165(2-3):222-5. No abstract available.

PMID:
2494736
15.

Limited sampling models for amonafide (NSC 308847) pharmacokinetics.

Ratain MJ, Staubus AE, Schilsky RL, Malspeis L.

Cancer Res. 1988 Jul 15;48(14):4127-30.

16.

Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion schedule.

Leiby JM, Grever MR, Staubus AE, Neidhart JA, Malspeis L.

J Natl Cancer Inst. 1988 May 18;80(6):447-9.

PMID:
2452888
17.

An area function method for estimating the apparent absorption rate constant.

Cheng H, Staubus AE, Shum L.

Pharm Res. 1988 Jan;5(1):57-60.

PMID:
3244611
18.

Pharmacokinetic studies of DISIDA disposition. II. Clinical studies.

Love JE, Shaffer P, Fraser IA, Staubus AE, Lott JA, Hinkle G, Carey LC, Ellison EC, Fabri PJ.

Eur J Nucl Med. 1988;14(9-10):436-40.

PMID:
3215183
19.

Pharmacokinetic studies of DISIDA disposition. I. Animal studies.

Fraser IA, Shaffer P, Love J, Staubus AE, Hinkle G, Olsen J, Carey LC, Fabri PJ, Ellison EC.

Eur J Nucl Med. 1988;14(9-10):431-5.

PMID:
3215182
20.

Parenteral nutrition: short term effects on hepatic clearance of sodium taurocholate and indocyanine green.

Fabri PJ, Deutsch S, Gower W Jr, Mirtallo JM, Staubus AE, Love JE Jr.

Clin Biochem. 1987 Feb;20(1):57-60.

PMID:
2882877
21.

Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.

Mays DC, Rogers SL, Guiler RC, Sharp DE, Hecht SG, Staubus AE, Gerber N.

J Pharmacol Exp Ther. 1986 Feb;236(2):364-73.

PMID:
3944766
22.

Measurement of water kinetics with deuterium oxide in lactating dairy cows.

Odwongo WO, Conrad HR, Staubus AE, Harrison JH.

J Dairy Sci. 1985 May;68(5):1155-64.

23.

The use of deuterium oxide for the prediction of body composition in live dairy cattle.

Odwongo WO, Conrad HR, Staubus AE.

J Nutr. 1984 Nov;114(11):2127-37.

PMID:
6092584
24.

Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routes.

Price JE, Barth RF, Johnson CW, Staubus AE.

Proc Soc Exp Biol Med. 1984 Nov;177(2):347-53.

PMID:
6091149
25.

An enzymatic kinetic method for the determination of 2'-deoxycoformycin in biological fluids.

Staubus AE, Weinrib AB, Malspeis L.

Biochem Pharmacol. 1984 May 15;33(10):1633-7.

PMID:
6610419
26.

The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.

Arnold ST, Jayaram HN, Harper GR, Litterst CL, Malspeis L, DeSouza JJ, Staubus AE, Ahluwalia GS, Wilson YA, Cooney DA.

Drug Metab Dispos. 1984 Mar-Apr;12(2):165-73.

PMID:
6144481
27.

Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system.

Reuning RH, Liao SH, Staubus AE, Ashcraft SB, Downs DA, Harrigan SE, Wiley JN, Wise DL.

J Pharmacokinet Biopharm. 1983 Aug;11(4):369-87.

PMID:
6422028
28.

Pharmacokinetics of 5,6-dihydro-5-azacytidine (NSC-264880) in the foxhound.

Malspeis L, Cheng H, Staubus AE.

Invest New Drugs. 1983;1(1):47-58.

PMID:
6206020
29.

Optimal perfusion rate determined for in situ intestinal absorption studies in rats.

Savina PM, Staubus AE, Gaginella TS, Smith DF.

J Pharm Sci. 1981 Mar;70(3):239-43.

PMID:
7264883
30.

Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems.

Reuning RH, Liao SH, Staubus AE.

NIDA Res Monogr. 1981;28:172-84.

PMID:
6791003
31.

Pharmacokinetics: an analysis of the method.

Staubus AE.

Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S91-6.

PMID:
7203954
32.

Clinical toxic effects of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY) with relevant pharmacokinetic parameters.

Neidhart JA, Staubus AE, Young D, King GW, Malspeis L.

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):251-5.

PMID:
7407759
33.

Urinary iodine excretion rates following intrathecal injections of iodinated organic carbonates.

Staubus AE, Newton BN, Klein LC, Weinrib AB, Kunz AL.

J Pharm Sci. 1979 Nov;68(11):1438-43.

PMID:
583163
34.

Plasma naltrexone kinetics after intravenous bolus administration in dogs and monkeys.

Reuning RH, Batra VK, Ludden TM, Jao MY, Morrison BE, McCarthy DA, Harrigan SE, Ashcraft SB, Sams RA, Bathala MS, Staubus AE, Malspeis L.

J Pharm Sci. 1979 Apr;68(4):411-6.

PMID:
108382
35.

Oral cytembena absorption and phase I--II studies.

Neidhart JA, Staubus AE, Young D, Balcerzak SP, Malspes IL.

Cancer Treat Rep. 1978 Mar;62(3):401-4.

PMID:
348307
36.

Saturation kinetics of iocetamic acid: Evaluation of indirect pharmacokinetic techniques and comparison with iopanoic acid.

Staubus AE, Berk RN, Loeb PM, Barnhart JL.

Invest Radiol. 1978 Jan-Feb;13(1):85-92.

PMID:
147248
37.

Letter: Biliary and urinary iopanoic acid excretion.

Nelson JA, Staubus AE.

Invest Radiol. 1976 Jan-Feb;11(1):63-4. No abstract available.

PMID:
1254424
38.
39.

Saturation kinetics of iopanoate in the dog.

Nelson JA, Staubus AE, Riegelman S.

Invest Radiol. 1975 Jul-Aug;10(4):371-7.

PMID:
1184327

Supplemental Content

Loading ...
Support Center